Exon

Not to be confused with axon, the projection of a neuron, or Exxon, a brand of fuel sold by ExxonMobil, or hexon, a viral protein.

For other uses, see Exon (disambiguation).

Introns are removed and exons joined in the process of RNA splicing.

An exon is any part of a gene that will form a part of the final mature RNA produced by that gene after introns have been removed by RNA splicing. The term exon refers to both the DNA sequence within a gene and to the corresponding sequence in RNA transcripts. In RNA splicing, introns are removed and exons are covalently joined to one another as part of generating the mature RNA. Just as the entire set of genes for a species constitutes the genome, the entire set of exons constitutes the exome.

History

The term exon derives from the expressed region and was coined by American biochemist Walter Gilbert in 1978: "The notion of the cistron… must be replaced by that of a transcription unit containing regions which will be lost from the mature messenger – which I suggest we call introns (for intragenic regions) – alternating with regions which will be expressed – exons."

This definition was originally made for protein-coding transcripts that are spliced before being translated. The term later came to include sequences removed from rRNA and tRNA, and other ncRNA and it also was used later for RNA molecules originating from different parts of the genome that are then ligated by trans-splicing.

Contribution to genomes and size distribution

Although unicellular eukaryotes such as yeast have either no introns or very few, metazoans and especially vertebrate genomes have a large fraction of non-coding DNA. For instance, in the human genome only 1.1% of the genome is spanned by exons, whereas 24% is in introns, with 75% of the genome being intergenic DNA. This can provide a practical advantage in omics-aided health care (such as precision medicine) because it makes commercialized whole exome sequencing a smaller and less expensive challenge than commercialized whole genome sequencing. The large variation in genome size and C-value across life forms has posed an interesting challenge called the C-value enigma.

Across all eukaryotic genes in GenBank, there were (in 2002), on average, 5.48 exons per gene. The average exon encoded 30-36 amino acids. While the longest exon in the human genome is 11555 bp long, several exons have been found to be only 2 bp long. A single-nucleotide exon has been reported from the Arabidopsis genome.

Structure and function

Exons in a messenger RNA precursor (pre-mRNA). Exons can include both sequences that code for amino acids (red) and untranslated sequences (grey). Introns — those parts of the pre-mRNA that are not in the mRNA — (blue) are removed, and the exons are joined (spliced) to form the final functional mRNA. The 5′ and 3′ ends of the mRNA are marked to differentiate the two untranslated regions (grey).

In protein-coding genes, the exons include both the protein-coding sequence and the 5′- and 3′-untranslated regions (UTR). Often the first exon includes both the 5′-UTR and the first part of the coding sequence, but exons containing only regions of 5′-UTR or (more rarely) 3′-UTR occur in some genes, i.e. the UTRs may contain introns. Some non-coding RNA transcripts also have exons and introns.

Mature mRNAs originating from the same gene need not include the same exons, since different introns in the pre-mRNA can be removed by the process of alternative splicing.

Exonization is the creation of a new exon, as a result of mutations in introns.

Experimental approaches using exons

Exon trapping or 'gene trapping' is a molecular biology technique that exploits the existence of the intron-exon splicing to find new genes. The first exon of a 'trapped' gene splices into the exon that is contained in the insertional DNA. This new exon contains the ORF for a reporter gene that can now be expressed using the enhancers that control the target gene. A scientist knows that a new gene has been trapped when the reporter gene is expressed.

Splicing can be experimentally modified so that targeted exons are excluded from mature mRNA transcripts by blocking the access of splice-directing small nuclear ribonucleoprotein particles (snRNPs) to pre-mRNA using Morpholino antisense oligos. This has become a standard technique in developmental biology. Morpholino oligos can also be targeted to prevent molecules that regulate splicing (e.g. splice enhancers, splice suppressors) from binding to pre-mRNA, altering patterns of splicing.

Common misuse of the term

Common incorrect uses of the term exon are that 'exons code for protein', or 'exons code for amino-acids' or 'exons are translated'. As indicated in this article exons may become part of a non-coding RNA or the untranslated region of mRNAs . These incorrect definitions (Feb 2022) are found on overall reputable sites [NHGRI],[Nature].

See also

• DBASS3/5
• Exitron
• Exon-intron database
• Exon shuffling
• Interrupted gene
• Outron
• Twintron
• Untranslated region (UTR)

References

Bibliography

• Zhang MQ (May 1998). "Statistical features of human exons and their flanking regions". Human Molecular Genetics. 7 (5): 919–32. doi:10.1093/hmg/7.5.919. PMID 9536098.
• Thanaraj TA, Robinson AJ (November 2000). "Prediction of exact boundaries of exons". Brief. Bioinform. 1 (4): 343–56. doi:10.1093/bib/1.4.343. PMID 11465052.

External links

• Exon-intron graphic maker